The Chemokine Receptor CCR8 Is a Target of Chimeric Antigen T Cells for Treating T Cell Malignancies

Diwei Zheng(Wuhan University), Peng Li(Chinese Academy of Sciences), Jie Yang(University of Cambridge), Qifa Liu(University of Science and Technology of China), Hongsheng Zhou(Ganzhou People's Hospital), Le Qin(Chinese Academy of Sciences), Youguo Long(Chinese Academy of Sciences), Qiting Wu(Chinese Academy of Sciences), Yangqiu Li(Jinan University), Zhaoyang Tang(Academy of Medical Sciences), Xinwen Chen(Guangzhou Experimental Station), Ruocong Zhao(Chinese Academy of Sciences), Zhiwu Jiang(Guangxi University), Wei Wei(Institute of Process Engineering), Yao Yao(Dalian Medical University), Yao Li(Zhengzhou University), Xindong Wang(Nanjing University of Chinese Medicine), Lin Cheng(Chinese Academy of Sciences), Jingxuan Shi(Guangzhou Women and Children Medical Center), Li-Hua Yang(Second Affiliated Hospital of Guangzhou Medical University), Suna Wang(National Institutes of Health), Pentao Liu(Hong Kong Science and Technology Parks Corporation)
Frontiers in Immunology
May 26, 2022
Cited by 14


Related Papers